Perspectives on cognitive domains, H₃ receptor ligands and neurological disease

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.13, Iss.10, 2004-10, pp. : 1237-1248

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent advances in histamine H₃/H₄ receptor ligands

By Stark Holger

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 6, 2003-06 ,pp. : 851-865

Informa Healthcare

Access to resources Recommend Favorite

Progress in Developing D3 Dopamine Receptor Ligands as Potential Therapeutic Agents for Neurological and Neuropsychiatric Disorders

Current Pharmaceutical Design, Vol. 9, Iss. 8, 2003-03 ,pp. : 643-671

Bentham Science Publishers

Access to resources Recommend Favorite

Histamine H3 Receptor Function and Ligands: Recent Developments

Mini Reviews in Medicinal Chemistry, Vol. 13, Iss. 1, 2013-01 ,pp. : 47-57

Bentham Science Publishers

Access to resources Recommend Favorite

Angiotensin ATReceptor Ligands: Do They Have Potential as Future Treatments for Neurological Disease?

By Rosenstiel P.

CNS Drugs, Vol. 16, Iss. 3, 2002-01 ,pp. : 145-153

Adis International

Access to resources Recommend Favorite

Characterization of binding sites for the 3 receptor ligands [ 3 H]PK11195 and [ 3 H]RO5-4864 in human brain

By Rao V.L.R. Butterworth R.F.

European Journal of Pharmacology, Vol. 340, Iss. 1, 1997-12 ,pp. : 89-99

Elsevier

Access to resources Recommend Favorite